Salk Institute for Biological Studies: A Step Towards Clinic-Ready Patient-Derived Organoids
March 08, 2024
March 08, 2024
LA JOLLA, California, March 8 (TNSres) -- The Salk Institute for Biological Studies issued the following news release:
* * *
Salk scientists test whether different commercial cell culture products affect organoid development and response to pancreatic cancer drugs
* * *
Pancreatic cancer has the highest mortality rate of all major cancers and is projected to become the second-leading cause of cancer-related deaths in the United States by 2030. . . .
* * *
Salk scientists test whether different commercial cell culture products affect organoid development and response to pancreatic cancer drugs
* * *
Pancreatic cancer has the highest mortality rate of all major cancers and is projected to become the second-leading cause of cancer-related deaths in the United States by 2030. . . .